Protech Sees 5% Bump After Raymond James Initiates Coverage

Posted on December 15, 2020 by Aaron Warwick

This morning Raymond James in Canda initiated coverage of Protech Home Medical (PTQQF or PTQ.V) with an outperform rating and a price target of $2.00 Canadian dollars. That price target represents about 40% upside from its closing price the day before of $1.44 on the Toronto exchange. Shares on both the US OTC and Toronto exchanges have been up around 5% throughout the day following this initiation report. I have written fairly extensively on PTQQF, including an update on this website yesterday, in tandem with the publication of a full article on Seeking Alpha. I plan to continue coverage of this stock on my Breakout Investor page as I believe the stock has much more upside than even the Raymond James report indicates.

Disclosure: I am long PTQQF and may buy or sell shares at any time.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x